Figure S2 from Merkel Cell Carcinoma Patients Presenting Without a Primary Lesion Have Elevated Markers of Immunity, Higher Tumor Mutation Burden, and Improved Survival

Autor: Paul Nghiem, Jaehyuk Choi, Timothy A. Chan, Seesha Takagishi, Tessa Marx, Ryan Doumani, Amy Bestick, Daniel Hippe, Kelly G. Paulson, Nadeem Riaz, Vladimir Makarov, Christopher W. Lewis, Natalie Vandeven
Rok vydání: 2023
DOI: 10.1158/1078-0432.22465560
Popis: Supplemental Figure 2. MCC-UP status predicts better survival among non-immunosuppressed patients with either stage IIIB or IV disease. Panel A depicts MCC-specific survival B illustrates overall survival and C indicated recurrence-free survival for 92 patients with stage IIIB MCC by unknown primary status. Panel D describes MCC-specific survival for 19 patients with stage IV MCC. MCC-specific survival analyses was completed using a competing-risks regression model with the competing risk being defined as death by all causes except MCC. Overall and recurrence-free survival was performed using the Cox-proportional hazards model.
Databáze: OpenAIRE